Cytomegalovirus Infection
📧 Sign up to get email alerts when something new happens for Cytomegalovirus Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-02-18Clinical Trial Update: Tissue Cytomegalovirus Viral Load and Associated Factors in Pediatric Patients Undergoing Colonoscopy
A completed clinical trial evaluated tissue cytomegalovirus viral load and associated factors in pediatric patients undergoing colonoscopy, …
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: Effectiveness of an Immune-guided Cytomegalovirus Infection Preventive Strategy Compared to a Universal Prophylactic Strategy in Renal Transplant Patients [Phase 3]
Phase 3 trial comparing an immune-guided cytomegalovirus prevention strategy to universal prophylaxis in kidney transplant recipients; curre…
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: Donor Cytomegalovirus-Specific Cytotoxic T-Lymphocytes in Treating Patients With a Persistent Cytomegalovirus Infection [Phase 2]
Phase 2 clinical trial evaluating donor CMV-specific cytotoxic T lymphocytes for persistent cytomegalovirus infection in patients with hemat…
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: Combination Letermovir and Standard of Care Antiviral for Enhanced Antiviral Response in Cytomegalovirus Infection in Lung Transplant Recipients [Phase 4]
A Phase 4 clinical trial is evaluating the combination of letermovir with standard-of-care antivirals for cytomegalovirus infection in lung …
-
CLINICAL_TRIALS trial_result · 2026-02-05Clinical Trial Update: Clinical and Genetic Analysis of Enlarged Vestibular Aqueducts
This clinical trial update reports on the clinical and genetic analysis of enlarged vestibular aqueducts in patients with sensorineural hear…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-02-02Clinical Trial Update: A Long-Term Extension Study to Evaluate the Immunogenicity and Safety of Cytomegalovirus (CMV) mRNA-1647 Vaccine [Phase 2]
Long-term extension study (Phase 2) evaluating immunogenicity and safety of CMV vaccine mRNA-1647; the trial has completed.
-
CLINICAL_TRIALS trial_result · 2026-01-30Clinical Trial Update: ValgaNciclovIR for CMV Viraemia in AdvaNced HIV diseAse [Phase 2]
A Phase 2 clinical trial evaluating valganciclovir for cytomegalovirus viraemia in advanced HIV disease is not yet recruiting.
-
CLINICAL_TRIALS trial_result · 2026-01-29Clinical Trial Update: A Study of Cytomegalovirus (CMV) Infection After Kidney Transplant in Adults in the United Kingdom
This clinical trial update reports a completed study on Cytomegalovirus infection in adult kidney transplant recipients in the United Kingdo…
-
CLINICAL_TRIALS research · 2026-01-28Clinical Trial Update: Infection Prophylaxis and Management in Treating Cytomegalovirus (CMV) Infection in Patients With Hematologic Malignancies Previously Treated With Donor Stem Cell Transplant
This clinical trial update describes ongoing strategies for CMV infection prophylaxis and management in patients with hematologic malignanci…
-
CLINICAL_TRIALS research · 2026-01-27Clinical Trial Update: Casting Light on HOst-cytomegaloviRUs Interaction in Solid Organ Transplantation
Active-not-recruiting clinical trial updating on host Cytomegalovirus interactions in solid organ transplantation, sponsored by University H…
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: Single Arm Pilot Trial of Letermovir for CMV Prophy in CAR T Cell [Phase 2]
This update describes a Phase 2 single-arm pilot trial of letermovir for cytomegalovirus prophylaxis in patients receiving CAR T-cell therap…
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: Efficacy of Extended Letermovir Prophylaxis to Prevent CMV Reactivation in High-Risk Chinese Adults Undergoing Allogeneic HSCT [NA]
The document reports a clinical trial evaluating extended letermovir prophylaxis to prevent CMV reactivation in high-risk Chinese adults und…
-
CLINICAL_TRIALS research · 2026-01-02Clinical Trial Update: Letermovir-based Dual Therapy for Treatment of Cytomegalovirus Infections [Phase 3]
A Phase 3 clinical trial is evaluating a letermovir-based dual therapy for treating cytomegalovirus infections and is currently recruiting.
-
CLINICAL_TRIALS research · 2025-12-22Clinical Trial Update: Strategic Help With Immunoglobulin to Enhance Protect Against Late Disease (CMV) [Phase 4]
A Phase 4 clinical trial is evaluating intravenous immunoglobulin to prevent late cytomegalovirus disease in organ transplant recipients and…
-
CLINICAL_TRIALS research · 2025-12-19Clinical Trial Update: Is Valacyclovir Non-inferior to Valganciclovir as CMV and EBV Prophylaxis in Kidney Transplant Recipients? A Single-Center Prospective Randomized Pilot Study [NA]
A single-center randomized pilot study comparing valacyclovir versus valganciclovir for CMV and EBV prophylaxis in kidney transplant recipie…
-
CLINICAL_TRIALS research · 2025-12-16Clinical Trial Update: VIROMARKERS GA n.101194735 - CMV and TTV Biomarkers Study Protocol
A study protocol investigating CMV and TTV biomarkers in allogeneic hematopoietic stem cell transplant recipients; currently not yet recruit…
-
CLINICAL_TRIALS research · 2025-12-16Clinical Trial Update: A Study of Maribavir in Adults With Kidney Failure Who Have a Cytomegalovirus (CMV) Infection After Transplantation
This clinical trial update describes a study of maribavir in adults with kidney failure and CMV infection after transplantation, which is cu…
-
CLINICAL_TRIALS trial_result · 2025-12-15Clinical Trial Update: A Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1647 Cytomegalovirus (CMV) Vaccine in Healthy Participants 16 to 40 Years of Age [Phase 3]
A Phase 3 trial evaluating the mRNA-1647 cytomegalovirus vaccine in healthy adults was terminated; this update reports the study status.
-
CLINICAL_TRIALS research · 2025-12-15Clinical Trial Update: A Study of mRNA-1647 Cytomegalovirus Vaccine in Healthy Participants 9 to 15 Years of Age and Participants 16 to 25 Years of Age [Phase 1, Phase 2]
Update on a Phase 1/2 clinical trial evaluating Moderna's mRNA-1647 vaccine for cytomegalovirus in healthy participants aged 9 to 25, curren…
-
CLINICAL_TRIALS research · 2025-12-05Clinical Trial Update: Efficacy and Safety of Leymovir Versus Valganciclovir in Prevention of Cytomegalovirus Infection and Cytomegalovirus Disease in Chinese Kidney Transplant Recipients [Phase 4]
Phase 4 clinical trial in Chinese kidney transplant recipients comparing Leymovir to valganciclovir for prevention of cytomegalovirus infect…
-
CLINICAL_TRIALS trial_result · 2025-12-04Clinical Trial Update: Feasibility of Saliva and Remote Monitoring of Active Cytomegalovirus (CMV) Infection and Symptoms During Ovarian Cancer Treatment
This completed feasibility trial evaluated saliva-based and remote monitoring approaches for detecting active cytomegalovirus infection and …
-
CLINICAL_TRIALS trial_result · 2025-12-04Clinical Trial Update: Cytomegalovirus (CMV) Vaccines: Reinfection and Antigenic Variation [NA]
This completed clinical trial update discusses cytomegalovirus vaccines and challenges related to reinfection and antigenic variation. The s…
-
CLINICAL_TRIALS research · 2025-12-04Clinical Trial Update: Phase II Trial of Maribavir for CMV in Patients With Lymphoid Malignancy on Bispecific Antibodies [Phase 2]
Phase II clinical trial evaluating maribavir for cytomegalovirus infection in patients with lymphoid malignancies on bispecific antibodies; …
-
CLINICAL_TRIALS research · 2025-11-28Clinical Trial Update: Impact of CMV-Specific Immune Reconstitution at the End of Letermovir Prophylaxis on the Development of Late Cytomegalovirus Infection in Hematopoietic Stem Cell Transplant Recipients (INMUNOEND)
A clinical trial investigating whether CMV-specific immune reconstitution after termination of letermovir prophylaxis influences the risk of…
-
CLINICAL_TRIALS research · 2025-11-18Clinical Trial Update: A Study of LIVTENCITY (Maribavir) in Adults With Cytomegalovirus (CMV) Infection After Transplantation in South Korea
This clinical trial update reports that Takeda’s LIVTENCITY (maribavir) is being studied in adults with cytomegalovirus infection after tran…